12,554
Views
1
CrossRef citations to date
0
Altmetric
EVIDENCE BASE UPDATE

ADHD Prevalence Among U.S. Children and Adolescents in 2022: Diagnosis, Severity, Co-Occurring Disorders, and Treatment

ORCID Icon, , , , , , & show all

References

  • AAP-AACAP-CHA. (2021). Declaration of a national emergency in child and adolescent mental health from the American Academy of Pediatrics, American Academy of Child and Adolescent Psychiatry and Children’s Hospital Association. https://www.aap.org/en/advocacy/child-and-adolescent-healthy-mental-development/aap-aacap-cha-declaration-of-a-national-emergency-in-child-and-adolescent-mental-health/
  • Abdelnour, E., Jansen, M. O., & Gold, J. A. (2022). ADHD diagnostic trends: Increased recognition or overdiagnosis? Missouri Medicine, 119(5), 467–473.
  • Akinbami, L. J., Liu, X., Pastor, P. N., & Reuben, C. A. (2011). Attention deficit hyperactivity disorder among children aged 5–17 years in the United States, 1998–2009. NCHS Data Brief, 70. https://www.cdc.gov/nchs/products/databriefs/db70.htm
  • Ali, M. M., West, K. D., Bagalman, E., & Sherry, T. B. (2023). Telepsychiatry use before and during the COVID-19 pandemic among children enrolled in Medicaid. Psychiatric Services, 74(6), 644–647. https://doi.org/10.1176/appi.ps.20220378
  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
  • Arruda, M., Arruda, R., Guidetti, V., Bigal, M. E., Landeira-Fernandez, J., Portugal, A., & Anunciação, L. (2022). Associated factors of attention-deficit/hyperactivity disorder diagnosis and psychostimulant use: A nationwide representative study. Pediatric Neurology, 128, 45–51. https://doi.org/10.1016/j.pediatrneurol.2021.11.008
  • Bailie, V., & Linden, M. A. (2023). Experiences of children and young people with attention deficit hyperactivity disorder (ADHD) during COVID-19 pandemic and lockdown restrictions. Disability and Rehabilitation, 46(3), 1–8. https://doi.org/10.1080/09638288.2022.2164366
  • Bannett, Y., Dahlen, A., Huffman, L. C., & Feldman, H. M. (2022). Primary care diagnosis and treatment of attention-deficit/hyperactivity disorder in school-age children: Trends and disparities during the COVID-19 pandemic. Journal of Developmental and Behavioral Pediatrics, 43(7), 386–392. https://doi.org/10.1097/DBP.0000000000001087
  • Barbaresi, W. J., Campbell, L., Diekroger, E. A., Froehlich, T. E., Liu, Y. H., O’Malley, E., Pelham, W. E. J., Power, T. J., Zinner, S. H., & Chan, E. (2020). Society for developmental and behavioral pediatrics clinical practice guideline for the assessment and treatment of children and adolescents with complex attention-deficit/hyperactivity disorder. Journal of Developmental & Behavioral Pediatrics, 41(2S), S35–S57. https://doi.org/10.1097/DBP.0000000000000770
  • Bitsko, R. H., Claussen, A. H., Lichstein, J., Black, L. I., Everett Jones, S., Danielson, M. L., Hoenig, J. M., Jack, S. P. D., Brody, D. J., Gyawali, S., Maenner, M. J., Warner, M., Holland, K. M., Perou, P., Crosby, A. E., Blumberg, S., Avenevoli, S., Kaminski, J. W., & Ghandour, R. (2022). Mental health surveillance among children – United States, 2013 – 2019. MMWR Supplements, 71(2), 1–48. https://doi.org/10.15585/mmwr.su7102a1
  • Bittner Gould, J., Walter, H. J., Bromberg, J., Correa, E. T., Hatoun, J., & Vernacchio, L. (2022). Impact of the coronavirus disease 2019 pandemic on mental health visits in pediatric primary care. Pediatrics, 150(6), e2022057176. https://doi.org/10.1542/peds.2022-057176
  • Board, A. R., Guy, G., Jones, C. M., & Hoots, B. (2020). Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty — United States, 2014–2019. Drug and Alcohol Dependence, 217, 108297. https://doi.org/10.1016/j.drugalcdep.2020.108297
  • Boyle, C. A., Boulet, S., Schieve, L. A., Cohen, R. A., Blumberg, S. J., Yeargin-Allsopp, M., Visser, S., & Kogan, M. D. (2011). Trends in the prevalence of developmental disabilities in US children, 1997-2008. Pediatrics, 127(6), 1034–1042. https://doi.org/10.1542/peds.2010-2989
  • Bozinovic, K., McLamb, F., O’Connell, K., Olander, N., Feng, Z., Haagensen, S., & Bozinovic, G. (2021). U.S. national, regional, and state-specific socioeconomic factors correlate with child and adolescent ADHD diagnoses pre-COVID-19 pandemic. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-01233-2
  • Breaux, R., Dvorsky, M. R., Marsh, N. P., Green, C. D., Cash, A. R., Shroff, D. M., Buchen, N., Langberg, J. M., & Becker, S. P. (2021). Prospective impact of COVID-19 on mental health functioning in adolescents with and without ADHD: Protective role of emotion regulation abilities. Journal of Child Psychology and Psychiatry, 62(9), 1132–1139. https://doi.org/10.1111/jcpp.13382
  • Burcu, M., Zito, J. M., Metcalfe, L., Underwood, H., & Safer, D. J. (2016). Trends in stimulant medication use in commercially insured youths and adults, 2010-2014. JAMA Psychiatry, 73(9), 992–993. https://doi.org/10.1001/jamapsychiatry.2016.1182
  • Centers for Disease Control and Prevention. (2005). Prevalence of diagnosis and medication treatment for ADHD - United States, 2003. MMWR Morbidity and Mortality Weekly Report, 54(34), 842–847. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5434a2.htm
  • Centers for Disease Control and Prevention. (2010). Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children — United States, 2003 and 2007. MMWR Morbidity and Mortality Weekly Report, 59(44), 1439–1443. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5944a3.htm
  • Chua, K.-P., Volerman, A., & Conti, R. M. (2021). Prescription drug dispensing to US children during the COVID-19 pandemic. Pediatrics, 148(2). https://doi.org/10.1542/peds.2021-049972
  • Coghill, D., Banaschewski, T., Cortese, S., Asherson, P., Brandeis, D., Buitelaar, J., Daley, D., Danckaerts, M., Dittmann, R. W., Doepfner, M., Ferrin, M., Hollis, C., Holtmann, M., Paramala, S., Sonuga-Barke, E., Soutullo, C., Steinhausen, H.-C., Van der Oord, S., Wong, I. C. K. … Simonoff, E. (2023). The management of ADHD in children and adolescents: Bringing evidence to the clinic: Perspective from the European ADHD Guidelines Group (EAGG). European Child & Adolescent Psychiatry, 32(8), 1337–1361. https://doi.org/10.1007/s00787-021-01871-x
  • Cree, R. A., Bitsko, R. H., Danielson, M. L., Wanga, V., Holbrook, J., Flory, K., Kubicek, L., Evans, S. W., Owens, J. S., & Cuffe, S. P. (2023). Surveillance of ADHD among children in the United States: Validity and reliability of parent report of provider diagnosis. Journal of Attention Disorders, 27(2), 111–123. https://doi.org/10.1177/10870547221131979
  • Cuffe, S. P., Visser, S. N., Holbrook, J. R., Danielson, M. L., Geryk, L. L., Wolraich, M. L., & McKeown, R. E. (2020). ADHD and psychiatric comorbidity: Functional outcomes in a school-based sample of children. Journal of Attention Disorders, 24(9), 1345–1354. https://doi.org/10.1177/1087054715613437
  • Cummings, J. R., Allen, L., Clennon, J., Ji, X., & Druss, B. G. (2017). Geographic access to specialty mental health care across high- and low-income US communities. JAMA Psychiatry, 74(5), 476–484. https://doi.org/10.1001/jamapsychiatry.2017.0303
  • Danielson, M. L., Bitsko, R. H., Ghandour, R. M., Holbrook, J. R., Kogan, M. D., & Blumberg, S. J. (2018). Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016. Journal of Clinical Child & Adolescent Psychology, 47(2), 199–212. https://doi.org/10.1080/15374416.2017.1417860
  • Danielson, M. L., Bohm, M. K., Newsome, K., Claussen, A. H., Kaminski, J. W., Grosse, S. G., Siwakoti, L., Arifkhanova, A., Bitsko, R. H., & Robinson, L. R. (2023). Trends in prescription stimulant fills among commercially insured children and adults — United States, 2016–2021. MMWR Morbidity and Mortality Weekly Report, 72(13), 327–332. https://doi.org/10.15585/mmwr.mm7213a1
  • Danielson, M. L., Charania, S., Holbrook, J., & Bitsko, R. H. (2021). 16.4 Evaluation of a single parent-reported item indicator of ADHD severity. The Journal of the American Academy of Child & Adolescent Psychiatry, 60(10), S190–S191. https://doi.org/10.1016/j.jaac.2021.09.177
  • Danielson, M. L., Holbrook, J. R., Bitsko, R. H., Newsome, K., Charania, S. N., McCord, R. F., Kogan, M. D., & Blumberg, S. J. (2022). State-level estimates of the prevalence of parent-reported ADHD diagnosis and treatment among U.S. children and adolescents, 2016 to 2019. Journal of Attention Disorders, 26(13), 1685–1697. https://doi.org/10.1177/10870547221099961
  • Danielson, M. L., Visser, S. N., Chronis-Tuscano, A., & DuPaul, G. J. (2018). A national description of treatment among U.S. children and adolescents with ADHD. Journal of Pediatrics, 192, 240–246. https://doi.org/10.1016/j.jpeds.2017.08.040
  • Dvorsky, M. R., Breaux, R., Cusick, C. N., Fredrick, J. W., Green, C., Steinberg, A., Langberg, J. M., Sciberras, E., & Becker, S. P. (2022). Coping with COVID-19: Longitudinal impact of the pandemic on adjustment and links with coping for adolescents with and without ADHD. Research on Child and Adolescent Psychopathology, 50(5), 605–619. https://doi.org/10.1007/s10802-021-00857-2
  • Egbert, A. H., Wilfley, D. E., Eddy, K. T., Boutelle, K. N., Zucker, N., Peterson, C. B., Celio Doyle, A., Le Grange, D., & Goldschmidt, A. B. (2018). Attention-deficit/hyperactivity disorder symptoms are associated with overeating with and without loss of control in youth with overweight/obesity. Childhood Obesity, 14(1), 50–57. https://doi.org/10.1089/chi.2017.0114
  • Evans, S. W., Owens, J. S., Wymbs, B. T., & Ray, A. R. (2018). Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder. Journal of Clinical Child & Adolescent Psychology, 47(2), 157–198. https://doi.org/10.1080/15374416.2017.1390757
  • Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015). Attention-deficit/hyperactivity disorder (ADHD). Nature Reviews Disease Primers, 1(1), 15–27. https://doi.org/10.1038/nrdp.2015.20
  • Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., Rohde, L. A., Yang, L., Cortese, S., Almagor, D., Stein, M. A., Albatti, T. H., Aljoudi, H. F., Alqahtani, M. M. J., Asherson, P., & Wang, Y. (2021). The World Federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 23(7), 519–529. https://doi.org/10.1016/j.neubiorev.2021.01.022
  • Federico, A., Zgodic, A., Flory, K., Hantman, R. M., Eberth, J. M., Mclain, A. C., & Bradshaw, J. (2024). Predictors of autism spectrum disorder and ADHD: Results from the national survey of children’s health. Disability and Health Journal, 17(1), 101512. https://doi.org/10.1016/j.dhjo.2023.101512
  • Friesen, K., & Markowsky, A. (2021). The diagnosis and management of anxiety in adolescents with comorbid ADHD. The Journal for Nurse Practitioners, 17(1), 65–69. https://doi.org/10.1016/j.nurpra.2020.08.014
  • Gerdes, A. C., Lawton, K. E., Haack, L. M., & Schneider, B. W. (2014). Latino parental help seeking for childhood ADHD. Administration and Policy in Mental Health and Mental Health Services Research, 41(4), 503–513. https://doi.org/10.1007/s10488-013-0487-3
  • Ghirardi, L., Larsson, H., Chang, Z., Chen, Q., Quinn, P. D., Hur, K., Gibbons, R. D., & D’Onofrio, B. M. (2020). Attention-deficit/hyperactivity disorder medication and unintentional injuries in children and adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 59(8), 944–951. https://doi.org/10.1016/j.jaac.2019.06.010
  • Göbel, K., Baumgarten, F., Kuntz, B., Hölling, H., & Schlack, R. (2018). ADHD in children and adolescents in Germany. Results of the cross-sectional KiGGS wave 2 study and trends. Journal of Health Monitoring, 19(3), 42–49. https://doi.org/10.17886/RKI-GBE-2018-085
  • Groenman, A. P., Janssen, T. W. P., & Oosterlaan, J. (2017). Childhood psychiatric disorders as risk factor for subsequent substance abuse: A meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 56(7), 556–569. https://doi.org/10.1016/j.jaac.2017.05.004
  • Hales, C. M., Kit, B. K., Gu, Q., & Ogden, C. L. (2018). Trends in prescription medication use among children and adolescents—United States, 1999-2014. JAMA, 319(19), 2009–2020. https://doi.org/10.1001/jama.2018.5690
  • Hoagwood, K. E., Kelleher, K., Zima, B. T., Perrin, J. M., Bilder, S., & Crystal, S. (2016). Ten-year trends in treatment services for children with attention deficit hyperactivity disorder enrolled in Medicaid. Health Affairs, 35(7), 1266–1270. https://doi.org/10.1377/hlthaff.2015.1423
  • Holton, K. F., & Nigg, J. T. (2016). The association of lifestyle factors and ADHD in children. Journal of Attention Disorders, 24(11), 1511–1520. https://doi.org/10.1177/1087054716646452
  • Kolbe, A., White, J., & Manocchio, T. (2022). Flexibilities in controlled substances prescribing and dispensing during the COVID-19 pandemic. https://aspe.hhs.gov/reports/covid-flexibilities
  • Lebrun-Harris, L. A., Ghandour, R. M., Kogan, M. D., & Warren, M. D. (2022). Five-year trends in US children’s health and well-being, 2016-2020. JAMA Pediatrics, 176(7), e220056–e220056. https://doi.org/10.1001/jamapediatrics.2022.0056
  • Liu, T., Lingam, R., Lycett, K., Mensah, F. K., Muller, J., Hiscocl, H., Huque, M. H., & Wake, M. (2018). Parent-reported prevalence and persistence of 19 common child health conditions. Archives of Disease in Childhod, 103(6), 548–556. https://doi.org/10.1136/archdischild-2017-313191
  • Metzger, A. N., & Hamilton, L. T. (2021). The stigma of ADHD: Teacher ratings of labeled students. Sociological Perspectives, 64(2), 258–279. https://doi.org/10.1177/0731121420937739
  • Morgan, P. L., & Hu, E. H. (2023). Sociodemographic disparities in ADHD diagnosis and treatment among U.S. elementary schoolchildren. Psychiatry Research, 327, 327. https://doi.org/10.1016/j.psychres.2023.115393
  • Nigg, J. (2013). Attention-deficit/hyperactivity disorder and adverse health outcomes [review]. Clinical Psychology Review, 33(2), 215–228. https://doi.org/10.1016/j.cpr.2012.11.005
  • Olfson, M., Druss, B. G., & Marcus, S. C. (2015). Trends in mental health care among children and adolescents. New England Journal of Medicine, 372(21), 2029–2038. https://doi.org/10.1056/NEJMsa1413512
  • Parker, J. D., Talih, M., Malec, D. J., Beresovsky, V., Carroll, M., Joe Fred Gonzalez, J., Hamilton, B. E., Ingram, D. D., Kochanek, K., McCarty, F., Moriarity, C., Shimizu, I., Strashny, A., & Ward, B. W. (2017). National Center for Health Statistics data presentation standards for proportions. Vital and Health Statistics, 2(175). https://www.cdc.gov/nchs/data/series/sr_02/sr02_175.pdf
  • Pastor, P. N., Reuben, C. A., Duran, C. R., & Hawkins, L. D. (2015). Association between diagnosed ADHD and selected characteristics among children aged 4–17 years: United States, 2011–2013. NCHS Data Brief, 201. https://www.cdc.gov/nchs/products/databriefs/db201.htm
  • Perou, R., Bitsko, R. H., Blumberg, S. J., Pastor, P., Ghandour, R. M., Gfroerer, J. C., Hedden, S. L., Crosby, A. E., Visser, S. N., Schieve, L. A., Parks, S. E., Hall, J. E., Brody, D., Simile, C. M., Thompson, W. W., Baio, J., Avenevoli, S., Kogan, M. D., & Huang, L. N. (2013). Mental health surveillance among children — United States, 2005–2011. MMWR Supplements, 62(Suppl 2), 1–35.
  • Pliszka, S., & AACAP Work Group on Quality Issues. (2007). Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 46(7), 894–921.
  • Radhakrishnan, L., Leeb, R., Bitsko, R. H., Carey, K., Gates, A., Holland, K. M., Hartnett, K. P., Kite-Powell, A., DeVies, J., Smith, A. R., van Santen, K. L., Crossen, S., Sheppard, M., Wotiz, S., Lane, R. I., Njai, R., Johnson, A. G., Winn, A. W., Kirking, H. L. … Anderson, K. N. (2022). Pediatric emergency department visits associated with mental health conditions before and during the COVID-19 pandemic — United States, January 2019–January 2022. Morbidity and Mortality Weekly Report, 71(8), 319–324. https://doi.org/10.15585/mmwr.mm7108e2
  • Rogers, M. A., & MacLean, J. (2023). ADHD symptoms increased during the COVID-19 pandemic: A meta-analysis. Journal of Attention Disorders, 27(8), 800–811. https://doi.org/10.1177/10870547231158750
  • Russell, G., Rodgers, L. R., Ukoumunne, O. C., & Ford, T. (2014). Prevalence of parent-reported ASD and ADHD in the UK: Findings from the Millennium cohort study. Journal of Autism and Developmental Disorders, 44(1), 31–40. https://doi.org/10.1007/s10803-013-1849-0
  • Safer, D. J. (2016). Recent trends in stimulant usage. Journal of Attention Disorders, 20(6), 471–477. https://doi.org/10.1177/1087054715605915
  • Sayal, K., Prasad, C., Daley, D., Ford, T., & Coghill, D. (2018). ADHD in children and young people: Prevalence, care pathways, and service provision. Lancet Psychiatry, 5(2), 175–186. https://doi.org/10.1016/S2215-0366(17)30167-0
  • Schein, J., Childress, A., Adams, J., Gagnon-Sanschagrin, P., Maitland, J., Qu, W., Cloutier, M., & Guérin, A. (2022). Treatment patterns among children and adolescents with attention-deficit/hyperactivity disorder in the United States – a retrospective claims analysis. BMC Psychiatry, 22(1), 555. https://doi.org/10.1186/s12888-022-04188-4
  • Shi, Y., Hunter Guevara, L. R., Dykhoff, H. J., Sangaralingham, L. R., Phelan, S., Zaccariello, M. J., & Warner, D. O. (2021). Racial disparities in diagnosis of attention-deficit/hyperactivity disorder in a US national birth cohort. JAMA Network Open, 4(3), e210321–e210321. https://doi.org/10.1001/jamanetworkopen.2021.0321
  • Slobodin, O., & Masalha, R. (2020). Challenges in ADHD care for ethnic minority children: A review of the current literature. Transcultural Psychiatry, 57(3), 468–483. https://doi.org/10.1177/1363461520902885
  • Spencer, P., Timpe, Z., Verlenden, J., Rasberry, C. N., Moore, S., Yeargin-Allsopp, M., Claussen, A. H., Lee, S., Murray, C., Tripathi, T., Conklin, S., Iachan, R., McConnell, L., Deng, X., & Pampati, S. (2023). Challenges experienced by U.S. K-12 public schools in serving students with special education needs or underlying health conditions during the COVID-19 pandemic and strategies for improved accessibility. Disability and Health Journal, 16(2), 101428. https://doi.org/10.1016/j.dhjo.2022.101428
  • Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015). Prevalence of attention-deficit/Hyperactivity disorder: A systematic review and meta-analysis. Pediatrics, 135(4), e994–e1001. https://doi.org/10.1542/peds.2014-3482
  • Toce, M. S., Michelson, K. A., Chen, K. Y., Hudgins, J. D., Olson, K. L., & Bourgeois, F. T. (2022). Trends in dispensing of controlled medications for US adolescents and young adults, 2008 to 2019. JAMA Pediatrics, 176(12), 1265–1266. https://doi.org/10.1001/jamapediatrics.2022.3312
  • U.S. Census Bureau. (2023). 2022 National survey of children’s health: Methodology report. https://www2.census.gov/programs-surveys/nsch/technical-documentation/methodology/2022-NSCH-Methodology-Report.pdf
  • U.S. Surgeon General. (2021). Protecting youth mental health: The U.S. surgeon general’s advisory. https://www.hhs.gov/sites/default/files/surgeon-general-youth-mental-health-advisory.pdf
  • Visser, S. N., Danielson, M. L., Bitsko, R. H., Holbrook, J. R., Kogan, M. D., Ghandour, R. M., Perou, R., & Blumberg, S. J. (2014). Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011. Journal of the American Academy of Child & Adolescent Psychiatry, 53(1), 34–46.e32. https://doi.org/10.1016/j.jaac.2013.09.001
  • Visser, S. N., Danielson, M. L., Bitsko, R. H., Perou, R., & Blumberg, S. J. (2013). Convergent validity of parent-reported attention-deficit/hyperactivity disorder diagnosis: A cross-study comparison. JAMA Pediatrics, 167(7), 674–675. https://doi.org/10.1001/jamapediatrics.2013.2364
  • Wolraich, M. L., Chan, E., Froehlich, T., Lynch, R. L., Bax, A., Redwine, S. T., Ihyembe, D., & Hagan, J. F., Jr. (2019). ADHD diagnosis and treatment guidelines: A historical perspective. Pediatrics, 144(4), e20191682. https://doi.org/10.1542/peds.2019-1682
  • Wolraich, M. L., Hagan, J. F., Allan, C., Chan, E., Davison, D., Earls, M., Evans, S. W., Flinn, S. K., Froehlich, T., Frost, J., Holbrook, J. R., Lehmann, C. U., Lessin, H. R., Okechukwu, K., Pierce, K. L., Winner, J. D., Zurhellen, W., & Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactive Disorder. (2019). Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 144(4), e20192528. https://doi.org/10.1542/peds.2019-2528
  • Wong, A. W. W. A., & Landes, S. D. (2022). Expanding understanding of racial-ethnic differences in ADHD prevalence rates among children to include Asians and Alaskan Natives/American Indians. Journal of Attention Disorders, 26(5), 747–754. https://doi.org/10.1177/10870547211027932
  • Yard, E., Radhakrishnan, L., Ballesteros, M. F., Sheppard, M., Gates, A., Stein, Z., Hartnett, K., Kite-Powell, A., Rodgers, L., Adjemian, J., Ehlman, D. C., Holland, K., Idaikkadar, N., Ivey-Stephenson, A., Martinez, P., Law, R., & Stone, D. M. (2021). Emergency department visits for suspected suicide attempts among persons aged 12–25 years before and during the COVID-19 pandemic — United States, January 2019–May 2021. Morbidity and Mortality Weekly Report, 70(24), 888–894. https://doi.org/10.15585/mmwr.mm7024e1
  • Yeh, M., Hough, R. L., McCabe, K., Lau, A., & Garland, A. (2004). Parental beliefs about the causes of child problems: Exploring racial/ethnic patterns. Journal of the American Academy of Child & Adolescent Psychiatry, 43(5), 605–612. https://doi.org/10.1097/00004583-200405000-00014
  • Zablotsky, B., & Black, L. I. (2020). Prevalence of children aged 3–17 with developmental disabilities, by urbanicity: United States, 2015–2018. National Health Statistics Reports, 139. https://www.cdc.gov/nchs/data/nhsr/nhsr139-508.pdf
  • Zablotsky, B., Black, L. I., Maenner, M. J., Schieve, L. A., Danielson, M. L., Bitsko, R. H., Blumberg, S. J., Kogan, M. D., & Boyle, C. A. (2019). Prevalence and trends of developmental disabilities among children in the US, 2009-2017. Pediatrics, 144(4), e20190811. https://doi.org/10.1542/peds.2019-0811

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.